Literature DB >> 23588321

Challenges in implementing genomic medicine: the Mayo Clinic Center for Individualized Medicine.

G Farrugia1, R M Weinshilboum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588321      PMCID: PMC3909951          DOI: 10.1038/clpt.2013.52

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  The impact of pharmacogenomics on the management of cardiac disease.

Authors:  N L Pereira; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2011-08-10       Impact factor: 6.875

2.  The Gordon Wilson Lecture. The Mayo model: one path to an academic medical center.

Authors:  Richard M Weinshilboum
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

3.  Program in pharmacogenomics at the Ohio State University Medical Center.

Authors:  Joseph P Kitzmiller; Peter J Embi; Kandamurugu Manickam; Kevin M Sweet; Mitch A Phelps; Rebecca D Jackson; Clay B Marsh; Wolfgang Sadee
Journal:  Pharmacogenomics       Date:  2012-05       Impact factor: 2.533

4.  Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.

Authors:  J M Pulley; J C Denny; J F Peterson; G R Bernard; C L Vnencak-Jones; A H Ramirez; J T Delaney; E Bowton; K Brothers; K Johnson; D C Crawford; J Schildcrout; D R Masys; H H Dilks; R A Wilke; E W Clayton; E Shultz; M Laposata; J McPherson; J N Jirjis; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2012-05-16       Impact factor: 6.875

  4 in total
  20 in total

1.  Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit.

Authors:  John Valgus; Kristin W Weitzel; Josh F Peterson; Daniel J Crona; Christine M Formea
Journal:  Am J Health Syst Pharm       Date:  2019-04-08       Impact factor: 2.637

2.  CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.

Authors:  Brian H Shirts; Joseph S Salama; Samuel J Aronson; Wendy K Chung; Stacy W Gray; Lucia A Hindorff; Gail P Jarvik; Sharon E Plon; Elena M Stoffel; Peter Z Tarczy-Hornoch; Eliezer M Van Allen; Karen E Weck; Christopher G Chute; Robert R Freimuth; Robert W Grundmeier; Andrea L Hartzler; Rongling Li; Peggy L Peissig; Josh F Peterson; Luke V Rasmussen; Justin B Starren; Marc S Williams; Casey L Overby
Journal:  J Am Med Inform Assoc       Date:  2015-07-03       Impact factor: 4.497

3.  Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.

Authors:  Yuan Ji; Jennifer M Skierka; Joseph H Blommel; Brenda E Moore; Douglas L VanCuyk; Jamie K Bruflat; Lisa M Peterson; Tamra L Veldhuizen; Numrah Fadra; Sandra E Peterson; Susan A Lagerstedt; Laura J Train; Linnea M Baudhuin; Eric W Klee; Matthew J Ferber; Suzette J Bielinski; Pedro J Caraballo; Richard M Weinshilboum; John L Black
Journal:  J Mol Diagn       Date:  2016-03-03       Impact factor: 5.568

4.  Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.

Authors:  Alan R Shuldiner; Kathleen Palmer; Ruth E Pakyz; Tameka D Alestock; Kristin A Maloney; Courtney O'Neill; Shaun Bhatty; Jamie Schub; Casey Lynnette Overby; Richard B Horenstein; Toni I Pollin; Mark D Kelemen; Amber L Beitelshees; Shawn W Robinson; Miriam G Blitzer; Patrick F McArdle; Lawrence Brown; Linda Jo Bone Jeng; Richard Y Zhao; Nicholas Ambulos; Mark R Vesely
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-03-10       Impact factor: 3.908

5.  Clinical pharmacogenetics implementation: approaches, successes, and challenges.

Authors:  Kristin W Weitzel; Amanda R Elsey; Taimour Y Langaee; Benjamin Burkley; David R Nessl; Aniwaa Owusu Obeng; Benjamin J Staley; Hui-Jia Dong; Robert W Allan; J Felix Liu; Rhonda M Cooper-Dehoff; R David Anderson; Michael Conlon; Michael J Clare-Salzler; David R Nelson; Julie A Johnson
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-03-10       Impact factor: 3.908

6.  Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.

Authors:  Suzette J Bielinski; Janet E Olson; Jyotishman Pathak; Richard M Weinshilboum; Liewei Wang; Kelly J Lyke; Euijung Ryu; Paul V Targonski; Michael D Van Norstrand; Matthew A Hathcock; Paul Y Takahashi; Jennifer B McCormick; Kiley J Johnson; Karen J Maschke; Carolyn R Rohrer Vitek; Marissa S Ellingson; Eric D Wieben; Gianrico Farrugia; Jody A Morrisette; Keri J Kruckeberg; Jamie K Bruflat; Lisa M Peterson; Joseph H Blommel; Jennifer M Skierka; Matthew J Ferber; John L Black; Linnea M Baudhuin; Eric W Klee; Jason L Ross; Tamra L Veldhuizen; Cloann G Schultz; Pedro J Caraballo; Robert R Freimuth; Christopher G Chute; Iftikhar J Kullo
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

Review 7.  Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.

Authors:  Henry M Dunnenberger; Kristine R Crews; James M Hoffman; Kelly E Caudle; Ulrich Broeckel; Scott C Howard; Robert J Hunkler; Teri E Klein; William E Evans; Mary V Relling
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-02       Impact factor: 13.820

8.  An inter-professional approach to personalized medicine education: one institution's experience.

Authors:  Christine M Formea; Wayne T Nicholson; Carolyn Rohrer Vitek
Journal:  Per Med       Date:  2015-03       Impact factor: 2.512

Review 9.  Biobanks and personalized medicine.

Authors:  J E Olson; S J Bielinski; E Ryu; E M Winkler; P Y Takahashi; J Pathak; J R Cerhan
Journal:  Clin Genet       Date:  2014-03-27       Impact factor: 4.438

10.  Genomic medicine, precision medicine, personalized medicine: what's in a name?

Authors:  D M Roden; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2013-08       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.